Aoxing Pharmaceutical Company, Inc.
AOXG · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,707 | $2,252 | $1,501 | $1,774 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2,707 | $2,252 | $1,501 | $1,774 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $57 | -$2 | $43 | -$1 |
| % Margin | – | – | – | – |
| Net Income | $57 | -$2 | -$0 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | -0 | -0 | -0 |
| % Growth | 2,199.7% | -306.3% | 60.7% | – |
| Operating Cash Flow | – | – | -$15 | – |
| Capital Expenditures | – | – | $0 | – |
| Free Cash Flow | – | – | -$15 | – |